Carregant...

Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1

The currently available anti-HIV-1 therapeutics is highly beneficial to infected patients. However, clinical failures occur as a result of the ability of HIV-1 to rapidly mutate. One approach to overcome drug resistance is to target HIV-1 proteins that are highly conserved among phylogenetically dis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:The Future of HIV-1 Therapeutics
Autors principals: Mori, Mattia, Kovalenko, Lesia, Lyonnais, Sébastien, Antaki, Danny, Torbett, Bruce E., Botta, Maurizio, Mirambeau, Gilles, Mély, Yves
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7122173/
https://ncbi.nlm.nih.gov/pubmed/25749978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/82_2015_433
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!